WallStSmart

CME Group Inc (CME)vsNasdaq Inc (NDAQ)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CME Group Inc generates 20% more annual revenue ($6.76B vs $5.61B). CME leads profitability with a 63.4% profit margin vs 35.0%. NDAQ appears more attractively valued with a PEG of 1.78. NDAQ earns a higher WallStSmart Score of 67/100 (B-).

CME

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 8.0Value: 4.3Quality: 5.0
Piotroski: 2/9Altman Z: 0.30

NDAQ

Strong Buy

67

out of 100

Grade: B-

Growth: 6.0Profit: 8.5Value: 5.0Quality: 5.0
Piotroski: 7/9Altman Z: 1.35

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CME4 strengths · Avg: 9.5/10
Profit MarginProfitability
63.4%10/10

Keeps 63 of every $100 in revenue as profit

Operating MarginProfitability
65.0%10/10

Strong operational efficiency at 65.0%

Market CapQuality
$94.44B9/10

Large-cap with strong market position

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

NDAQ3 strengths · Avg: 9.7/10
Profit MarginProfitability
35.0%10/10

Keeps 35 of every $100 in revenue as profit

Operating MarginProfitability
49.3%10/10

Strong operational efficiency at 49.3%

Market CapQuality
$52.33B9/10

Large-cap with strong market position

Areas to Watch

CME4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.8%4/10

0.8% revenue growth

EPS GrowthGrowth
2.5%4/10

2.5% earnings growth

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
4.702/10

Expensive relative to growth rate

NDAQ3 concerns · Avg: 3.3/10
PEG RatioValuation
1.784/10

Expensive relative to growth rate

P/E RatioValuation
27.3x4/10

Moderate valuation

Altman Z-ScoreHealth
1.352/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CME

The strongest argument for CME centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 63.4% and operating margin at 65.0%.

Bull Case : NDAQ

The strongest argument for NDAQ centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 35.0% and operating margin at 49.3%. Revenue growth of 14.9% demonstrates continued momentum.

Bear Case : CME

The primary concerns for CME are Revenue Growth, EPS Growth, Piotroski F-Score.

Bear Case : NDAQ

The primary concerns for NDAQ are PEG Ratio, P/E Ratio, Altman Z-Score.

Key Dynamics to Monitor

CME profiles as a value stock while NDAQ is a mature play — different risk/reward profiles.

NDAQ carries more volatility with a beta of 0.97 — expect wider price swings.

NDAQ is growing revenue faster at 14.9% — sustainability is the question.

CME generates stronger free cash flow (924M), providing more financial flexibility.

Bottom Line

NDAQ scores higher overall (67/100 vs 55/100), backed by strong 35.0% margins and 14.9% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CME Group Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures.

Visit Website →

Nasdaq Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

Nasdaq, Inc. is an American multinational financial services corporation that owns and operates stock exchanges in the United States and Europe. It is headquartered in New York City.

Visit Website →

Want to dig deeper into these stocks?